1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow BRCA1 Gene Mutation: new trials by email Literature Review of BRCA1 Gene Mutation trials Research Report on BRCA1 Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Laboratory Biomarker Analysis, Mirvetuximab Soravtansine, Pharmacokinetic Study - BRCA1 Gene Mutation, BRCA2 Gene Mutation | Phase 1 | Completed | Ohio State University Comprehensive Cancer Center | 25 | 2018-07-12 | 2025-02-13 |
| Cancer Prevention in Women With a BRCA Mutation Follow-up Telephone Genetic Counselling - BRCA1 Gene Mutation, BRCA2 Gene Mutation | Phase 1 | Unknown | Women's College Hospital | 300 | 2015-01-01 | 2016-06-09 |
Ovarian Neoplasms (2) · Breast Neoplasms (1) · Fallopian Tube Neoplasms (1) · Neoplasms (1)
Adnexal Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Gonadal Disorders (2) · Neoplasms by Site (2) · Ovarian Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Breast Diseases (1) · Fallopian Tube Diseases (1)
Pharmacogenomic Variants (1) · mirvetuximab soravtansine (1) · rucaparib (1)
Ohio State University Comprehensive Cancer Center (1) · Women's College Hospital (1)
Canada (1) · United States (1)
Floor Backes, MD (1) · Kelly Metcalfe, Dr. (1)